Bonneau C - Search Results

1

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.

Jeannot E, Latouche A, Bonneau C, Calméjane MA, Beaufort C, Ruigrok-Ritstier K, Bataillon G, Larbi Chérif L, Dupain C, Lecerf C, Popovic M, de la Rochefordière A, Lecuru F, Fourchotte V, Jordanova ES, von der Leyen H, Tran-Perennou C, Legrier ME, Dureau S, Raizonville L, Bello Roufai D, Le Tourneau C, Bièche I, Rouzier R, Berns EMJJ, Kamal M, Scholl S. Jeannot E, et al. Among authors: bonneau c. Clin Cancer Res. 2021 Nov 1;27(21):5869-5877. doi: 10.1158/1078-0432.CCR-21-0625. Epub 2021 Jul 1. Clin Cancer Res. 2021. PMID: 34210686 Free PMC article.

2

[Cancer and pregnancy].

Maulard A, Bonneau C, Selleret L, Atallah D, Rouzier R. Maulard A, et al. Among authors: bonneau c. Rev Prat. 2012 Sep;62(7):954-9. Rev Prat. 2012. PMID: 23236867 French.

3

Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.

Bonneau C, Thomassin-Naggara I, Dechoux S, Cortez A, Darai E, Rouzier R. Bonneau C, et al. Acta Obstet Gynecol Scand. 2014 Mar;93(3):261-8. doi: 10.1111/aogs.12325. Acta Obstet Gynecol Scand. 2014. PMID: 24372487 Free article.

4

[Epidemiology and risk factors for cancer of the uterus].

Bonneau C, Perrin M, Koskas M, Genin AS, Rouzier R. Bonneau C, et al. Rev Prat. 2014 Jun;64(6):774-9. Rev Prat. 2014. PMID: 25090759 French.

5

[Life after uterine cancer].

Koskas M, Rodier JM, Bretel JJ, Bonneau C, Luton D, Touboul C, Rouzier R. Koskas M, et al. Among authors: bonneau c. Rev Prat. 2014 Jun;64(6):816-20. Rev Prat. 2014. PMID: 25090768 French.

6

CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.

Pelissier A, Bonneau C, Chéreau E, de La Motte Rouge T, Fourchotte V, Daraï E, Rouzier R. Pelissier A, et al. Among authors: bonneau c. Gynecol Oncol. 2014 Dec;135(3):542-6. doi: 10.1016/j.ygyno.2014.09.005. Epub 2014 Sep 16. Gynecol Oncol. 2014. PMID: 25223808

7

Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.

Bonneau C, Rouzier R, Geyl C, Cortez A, Castela M, Lis R, Daraï E, Touboul C. Bonneau C, et al. Gynecol Oncol. 2015 Jan;136(1):112-20. doi: 10.1016/j.ygyno.2014.10.024. Epub 2014 Nov 1. Gynecol Oncol. 2015. PMID: 25449309

8

Association of the number of sentinel lymph nodes harvested with survival in breast cancer.

Bonneau C, Bendifallah S, Reyal F, Rossi L, Rouzier R. Bonneau C, et al. Eur J Surg Oncol. 2015 Jan;41(1):52-8. doi: 10.1016/j.ejso.2014.11.004. Epub 2014 Nov 17. Eur J Surg Oncol. 2015. PMID: 25466979

9

Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.

Bonneau C, Hequet D, Estevez JP, Pouget N, Rouzier R. Bonneau C, et al. Eur J Surg Oncol. 2015 Aug;41(8):998-1004. doi: 10.1016/j.ejso.2015.04.003. Epub 2015 Apr 25. Eur J Surg Oncol. 2015. PMID: 25986854 Clinical Trial.

10

Predictive and Prognostic Value of the TauProtein in Breast Cancer.

Bonneau C, Gurard-Levin ZA, Andre F, Pusztai L, Rouzier R. Bonneau C, et al. Anticancer Res. 2015 Oct;35(10):5179-84. Anticancer Res. 2015. PMID: 26408675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page